Meanwhile, the silencing of β-catenin decreased the CSC phenotype mediated by FOXC1 overexpression, suggesting that FOXC1 induces CSC-like characteristics in NSCLC by promoting β-catenin expression [77]. This evidence concerns the gene FOXC1 and non-small cell lung carcinoma.